SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-025964
Filing Date
2020-09-22
Accepted
2020-09-22 19:11:27
Documents
1
Period of Report
2020-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9501
  Complete submission text file 0000899243-20-025964.txt   11826
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Reporting) CIK: 0001224962 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 201190605

Mailing Address C/O PERCEPTIVE ADVISORS LLC 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address C/O PERCEPTIVE ADVISORS LLC 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5340
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) CIK: 0001249675 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 201190606

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)